No Data
No Data
Tonghua Jinma (000766.SZ): New drug clinical trials involve multiple hospitals
Gelonghui, May 30, 丨 Tonghua Jinma (000766.SZ) held a performance briefing on May 29, 2024. Regarding “whether the company's new drug Peking Union Medical College Hospital has endorsed it,” the company replied that the clinical trials of the company's new drug involved many hospitals. Currently, the new drug has completed the deconstruction work. See the decluttering announcement for details.
Tonghua Jinma (000766.SZ): The new drug amber octahydroaminoacridine tablets have now completed investigation, statistical analysis reports and clinical trial summary reports
Gelonghui May 30丨Tonghua Jinma (000766.SZ) held a performance briefing on May 29, 2024 to discuss “Can new drug submissions be detected as soon as possible at the Drug Evaluation Center of the State Drug Administration?” The company replied that the company's new drug, amber octahydroaminoacridine tablets, has now completed the investigation, statistical analysis report, and clinical trial summary report. The next step is to submit a marketing application for the new drug to CDE. Currently, in accordance with CDE related requirements, the company is proceeding normally according to the established work plan.
Tonghua Jinma (000766.SZ): We have built a professional and dedicated new drug synthesis and formulation workshop. The design capacity can meet the medication needs of patients with Alzheimer's disease in China
Gelonghui, May 30丨Tonghua Jinma (000766.SZ) held a performance briefing on May 29, 2024 to discuss “how much annual production can the production line support for the subsequent launch of new drugs?” The company replied that the company has a professional and dedicated new drug synthesis and formulation workshop, the production system is built according to GMP requirements, and the design capacity can meet the medication needs of patients with Alzheimer's disease in China.
These 4 Measures Indicate That Tonghua Golden-Horse Pharmaceutical Industry CoLtd (SZSE:000766) Is Using Debt Reasonably Well
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of permanent loss is the risk I worry about... and every practical investor I know wor
Tonghua Jinma (000766.SZ) announced first-quarter results, net profit of 9.1863 million yuan, an increase of 31.94%
Tonghua Jinma (000766.SZ) released its report for the first quarter of 2024, achieving an operating income of 2.9 during the reporting period...
Optimistic Investors Push Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd (SZSE:000766) Shares Up 27% But Growth Is Lacking
Those holding Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd (SZSE:000766) shares would be relieved that the share price has rebounded 27% in the last thirty days, but it needs to keep going to r
No Data